Method of Treating TRX Mediated Diseases

Details for Australian Patent Application No. 2008202913 (hide)

Owner Sloan-Kettering Institute for Cancer Research

Inventors Rifkind, Richard A.; Richon, Victoria M.; Butler, Lisa M.; Marks, Paul A.

Agent Cullens

Pub. Number AU-B-2008202913

Parent 2005227400

Filing date 2 July 2008

Wipo publication date 24 July 2008

Acceptance publication date 7 January 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

24 July 2008 Application Open to Public Inspection

  Published as AU-B-2008202913

24 July 2008 Complete Application Filed

7 January 2010 Application Accepted

  Published as AU-B-2008202913

6 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202914-Tandem repeat DNA constructs producing proteins that attack plant pathogenic viruses, fungi, and bacteria by disrupting transcription factors essential for replication thereof in plants

2008202912-Transgenic Animals for Producing Specific Isotyes of Human Antibodies Via Non-Cognate Switch Regions